Defense Secretary Pete Hegseth announced on July 15, 2026, that the Pentagon will implement annual testosterone deficiency screenings for active-duty service members aged 30 and older. This policy aims to enhance military readiness and support long-term health. The testing will be integrated into the existing annual health assessments for these service members, while those younger than 30 may opt for the screening voluntarily.
In a video statement, Hegseth emphasized that the initiative is focused on health rather than performance enhancement, stating, "It's about restoring and optimizing your natural capabilities." The Department of Defense did not provide additional comments when contacted.
The policy will require active-duty personnel over 30 to undergo testosterone screenings as part of their yearly medical evaluations. If low testosterone levels are detected, treatment options, including testosterone replacement therapy, will be available but not mandatory.
Dr. Peter J. Snyder, who has conducted significant research on testosterone, expressed skepticism regarding the necessity of routine screenings, noting that low testosterone is rare in men up to age 79. He stated that testing should only be conducted for individuals showing symptoms of low testosterone and raised concerns about the practicalities of conducting these tests in a military setting.
The Department of Defense has not clarified whether female service members will be included in the screening program. Low testosterone can affect women, but treatment typically involves lifestyle changes rather than medication, and testosterone therapy for women is not approved. Hegseth's announcement comes amid scrutiny of his personnel decisions impacting female service members, including blocking promotions for several senior officers, which critics argue may hinder opportunities for women and minority officers.